Evidence map›Paper›PMID 42517933›Full record

ArticleArchives of microbiology2026

Novel antibiofilm strategies against Pseudomonas aeruginosa NG4 using oleic acid and indole-3-butyric acid.

Humma Niaz Malik, Subhasree Ray, Prasun Kumar

Abstract read
PubMed Publisher
In one paragraph

Article in Archives of microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Humma Niaz MalikDepartment of Life Science, School of Bio-science and Technology, Sharda University, Greater Noida, Uttar Pradesh, India.
Subhasree RayDepartment of Life Science, School of Bio-science and Technology, Sharda University, Greater Noida, Uttar Pradesh, India.
Prasun KumarDepartment of Biotechnology, School of Bio-science and Technology, Sharda University, Greater Noida, Uttar Pradesh, India. prasun.kumar6@sharda.ac.in.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Biofilm-associated infections caused by Pseudomonas aeruginosa are highly tolerant to conventional antibiotics, driving the search for novel agents capable of disrupting biofilm formation and associated virulence traits. In this study, the antibiofilm, anti-motility, and growth inhibitory effects of indole-3-butyric acid (IBA) and oleic acid (OA) were evaluated against pathogenic P. aeruginosa NG4. Biofilm biomass was quantified by crystal violet staining. The swarming and swimming motility were assessed on semi-solid agar, and planktonic growth was measured spectrophotometrically. Confocal laser scanning microscopy (CLSM) was used to visualise the biofilm structure. Both IBA and OA exhibited potent antibiofilm activity at low concentrations, with ~ 50% and ~ 54% inhibition, respectively, at 5 µg/mL, without affecting planktonic growth. Higher concentrations impaired bacterial proliferation, and both agents significantly reduced swarming motility, with OA exerting slightly greater inhibition. A significant breakdown of biofilm architecture was evident in CLSM images following treatment. To the best of our knowledge, this is the first study to demonstrate that IBA and OA exert significant antibiofilm and anti-motility effects against P. aeruginosa NG4 at low concentrations under the conditions tested, providing a foundation for future mechanistic and biological investigations.

Indexed as

Anti-Bacterial AgentsBiofilmsIndolesOleic AcidPseudomonas aeruginosaMicrobial Sensitivity TestsMicroscopy, ConfocalAnti-Bacterial Agentsindolebutyric acidIndolesOleic AcidBiofilm inhibitionIndole-3-butyric acidOleic acidPseudomonas aeruginosaSwarming and swimming motility

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.